Nippon India Nifty Pharma ETF
Open
27.09
High
27.09
Low
26.98
Mkt cap
1,749,172.25
P/E ratio
49.53
Div yield
0.61
Nippon India Nifty Pharma ETF - PHARMABEES
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Fund Type
|
Global Class Assets Name
|
Equity
|
|
Category
|
Equity - Pharma & Healthcare
|
|
Largest Sector
|
|
|
Leveraged Fund (Y/N)
|
-
|
|
Inverse Fund (Y/N)
|
-
|
|
Index Fund (Y/N)
|
-
|
|
Fund of Funds (Y/N)
|
-
|
|
Day Open
|
27.09 |
|
Day Close
|
27.09
|
|
Intraday Low
|
26.98
|
|
Intraday High
|
27.26
Open
|
|
iNAV/ Return Previous Day
|
0.11%
|
|
Return 5 years
|
0%
|
|
Return Since Inception
|
15%
|
|
Intraday Volume
|
0
|
|
Shares Outstanding
|
-
|
|
Dividend Frequency
|
0
|
|
Dividend Yield
|
0.61
|
Financial Statistics
| Expense Ratio | 0.21|
| Price Earning Ratio | 49.53 |
| Standard Deviation 12 Months | 0.76 |
| Tracking Error | 0.0014 |
| Sharpe Ratio 12 Months | 0.05 |
| Alpha 12 Months | -0.0009 |
| Beta 12 Months | 0.999 |
| Name | % Holding |
| Divi's Laboratories Limited | 8.32 |
| Lupin Limited | 6.13 |
| Aurobindo Pharma Limited | 5.35 |
| Torrent Pharmaceuticals Limited | 5.22 |
| Zydus Lifesciences Limited | 4.16 |
| Alkem Laboratories Limited | 3.54 |
| Mankind Pharma Limited | 3.01 |
| Sun Pharmaceutical Industries Limited | 22.53 |
| Glenmark Pharmaceuticals Limited | 2.91 |
| Laurus Labs Limited | 2.42 |
Administration
Manager
Jitendra Tolani
Nippon Life India Asset Management Limited
Address: Nippon Life India Asset Management Limited 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013
Address: Nippon Life India Asset Management Limited 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013